Publication | Closed Access
Serum Cripto‐1 is a novel biomarker for non‐small cell lung cancer diagnosis and prognosis
24
Citations
24
References
2015
Year
In conclusion, measurement of serum CR-1 is a useful diagnostic and prognostic marker for NSCLC patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1